Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen

Acta Haematologica

Volumn 126, Issue 2, 2011, Pages 122-128

  Inoue, Daichi ^a,c   Maruyama, Kyoko ^b   Aoki, Kazunari ^a   Nagano, Seiji ^a   Maruoka, Hayato ^a   Imai, Yukihiro ^a   Ito, Kiminari ^b   Ishikawa, Takayuki ^a   Takahashi, Takayuki ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antigen presenting cells; Blastic plasmacytoid dendritic cell neoplasm; CD13; CD40 ligand; Dendritic cells; IL 3

Indexed keywords

B7 ANTIGEN; CD123 ANTIGEN; CD33 ANTIGEN; CD40 LIGAND; CD45 ANTIGEN; CD56 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; CYTARABINE; DNA NUCLEOTIDYLEXOTRANSFERASE; ETOPOSIDE; INTERLEUKIN 3; MICROSOMAL AMINOPEPTIDASE;

AGED; ANGINA PECTORIS; ANTIGEN EXPRESSION; ARTICLE; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER INFILTRATION; CASE REPORT; CELL INFILTRATION; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; CRYOPRESERVATION; DENDRITIC CELL SARCOMA; EYELID CANCER; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SOFT TISSUE TUMOR; TUMOR BIOPSY; TUMOR CELL; TUMOR REGRESSION; VISUAL FIELD DEFECT;

AGED, 80 AND OVER; ANEMIA; ANTIGENS, CD13; BONE MARROW NEOPLASMS; DENDRITIC CELLS; HUMANS; MALE; NEOPLASMS, PLASMA CELL; ORBITAL NEOPLASMS;

EID: 79959471951     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000328180     Document Type: Article

References (21)

1. Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood K, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, Shaw AS, Petrella T, Stein H, Isaacson PG, Facchetti F, Mason DY: Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008; 111: 3778-3792.
2. Urosevic M, Conrad C, Kamarashev J, Asagoe K, Cozzio A, Burg G, Dummer R: CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol 2005; 36: 1020-1024. (Pubitemid 41253390)
3. Pilichowska ME, Fleming MD, Pinkus JL, Pinkus GS: CD4+/CD56+ hematodermic neoplasm ('blastic natural killer cell lymphoma'): Neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. Am J Clin Pathol 2007; 128: 445-453. (Pubitemid 47479978)
4. DiGiuseppe JA, Louie DC, Williams JE, Miller DT, Griffin CA, Mann RB, Borowitz MJ: Blastic natural killer cell leukemia/lymphoma: A clinicopathologic study. Am J Surg Pathol 1997; 21: 1223-1230.
5. Chaperot L, Bendriss N, Manches O, Gressin R, Maynadie M, Trimoreau F, Orfeuvre H, Corront B, Feuillard J, Sotto JJ, Bensa JC, Briere F, Plumas J, Jacob MC: Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97: 3210-3217.
6. Jacob MC, Chaperot L, Mossuz P, Feuillard J, Valensi F, Leroux D, Bene MC, Bensa JC, Briere F, Plumas J: CD4+ CD56+ lineage negative malignancies: A new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003; 88: 941-955. (Pubitemid 37128095)
7. Herling M, Teitell MA, Shen RR, Medeiros LJ, Jones D: TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood 2003; 101: 5007-5009. (Pubitemid 36857765)
8. Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadie M, Machet L, Casasnovas O, Vergier B, Teitell MA: TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol 2004; 122: 307-313. (Pubitemid 38971364)
9. Petrella T, Bagot M, Willemze R, Beylot-Barry M, Vergier B, Delaunay M, Meijer CJ, Courville P, Joly P, Grange F, De Muret A, Machet L, Dompmartin A, Bosq J, Durlach A, Bernard P, Dalac S, Dechelotte P, D'Incan M, Wechsler J, Teitell MA: Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): A review. Am J Clin Pathol 2005; 123: 662-675. (Pubitemid 40586484)
10. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and Tcell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4- CT98-3936. Leukemia 2003; 17: 2257-2317. (Pubitemid 38072572)
11. Makino S, Harada M, Akashi K, Taniguchi S, Shibuya T, Inaba S, Niho Y: A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without rate-controlled freezing. Bone Marrow Transplant 1991; 8: 239-244.
12. Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dompmartin A, d'Incan M, Maubec E, Grange F, Dereure O, Prey S, Barete S, Wetterwald M, Fraitag S, Petrella T: Blastic plasmacytoid dendritic cell neoplasm: Is transplantation the treatment of choice? Br J Dermatol 2010; 162: 74-79.
13. Garnache-Ottou F, Chaperot L, Biichle S, Ferrand C, Remy-Martin JP, Deconinck E, de Tailly PD, Bulabois B, Poulet J, Kuhlein E, Jacob MC, Salaun V, Arock M, Drenou B, Schillinger F, Seilles E, Tiberghien P, Bensa JC, Plumas J, Saas P: Expression of the myeloid- associated marker CD33 is not an exclusive factor for leukemic plasmacytoid dendritic cells. Blood 2005; 105: 1256-1264. (Pubitemid 40170901)
14. Giagounidis AA, Heinsch M, Haase S, Aul C: Early plasmacytoid dendritic cell leukemia/ lymphoma coexpressing myeloid antigenes. Ann Hematol 2004; 83: 716-721. (Pubitemid 39440217)
15. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997; 185: 1101-1111. (Pubitemid 27136802)
16. Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH: Id2 and id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre- DC1. Evidence for a lymphoid origin of pre- DC2. J Exp Med 2000; 192: 1775-1784.
17. Orazi A, Chiu R, O'Malley DP, Czader M, Allen SL, An C, Vance GH: Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology. Mod Pathol 2006; 19: 1536-1545. (Pubitemid 44789921)
18. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D: CD56(+) TdT(+) blastic natural killer cell tumor of the skin: A primitive systemic malignancy related to myelomonocytic leukemia. Cancer 2002; 94: 2401-2408. (Pubitemid 34457121)
19. Shigematsu H, Reizis B, Iwasaki H, Mizuno S, Hu D, Traver D, Leder P, Sakaguchi N, Akashi K: Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 2004; 21: 43-53. (Pubitemid 38925266)
20. Wada H, Masuda K, Satoh R, Kakugawa K, Ikawa T, Katsura Y, Kawamoto H: Adult Tcell progenitors retain myeloid potential. Nature 2008; 452: 768-772. (Pubitemid 351521082)
21. Mina-Osorio P: The moonlighting enzyme CD13: Old and new functions to target. Trends Mol Med 2008; 14: 361-371.